凯普生物：“六项呼吸道病原体核酸检测试剂盒”取得注册证

Group 1 - The core point of the article is that Capbio has received a medical device registration certificate for its "Six Pathogen Nucleic Acid Detection Kit" from the National Medical Products Administration of China [1] - Capbio's revenue composition for the first half of 2025 is as follows: molecular diagnostic products account for 67.65%, medical testing services account for 29.07%, and medical service income accounts for 3.27% [1] - As of the report date, Capbio's market capitalization is 3.7 billion yuan [1] Group 2 - The article also mentions a competitive situation in the beverage industry, where Nongfu Spring's new green bottle has led to a significant decline in market share for Yibao, dropping nearly 5 percentage points [1]